Categories AlphaGraphs, Earnings, Health Care

LLY Earnings: Key quarterly highlights from Eli Lilly’s Q2 2023 financial results

Eli Lilly and Company (NYSE: LLY) reported second quarter 2023 earnings results today.

Revenue increased 28% to $8.3 billion compared to the same period a year ago, fueled by volume-driven growth from Mounjaro, Verzenio, Jardiance and Taltz, as well as the sale of rights for Baqsimi.

Reported net income grew 85% to $1.76 billion, or $1.95 per share, compared to last year. Adjusted EPS rose 69% to $2.11.

Both revenue and earnings beat expectations, sending the stock up by 7% in premarket hours on Tuesday.  

The company raised its guidance for the full year of 2023. Revenue is now expected to be $33.4-33.9 billion. Reported EPS is expected to be $9.20-9.40 while adjusted EPS is projected to be $9.70-9.90.

Prior performance

Most Popular

DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY

Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales

CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates

Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings

ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results

Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top